Beta Bionics (BBNX) Invested Capital (2023 - 2026)

Beta Bionics' Invested Capital history runs 4 years deep, the most recent figure standing at $271.2 million for Q1 2026.

• In Q1 2026, Invested Capital fell 13.55% year-over-year to $271.2 million; the TTM figure through Mar 2026 stood at $271.2 million (down 13.55% YoY), while the FY2025 annual figure was $287.6 million, up 217.22% from the prior year.
• Invested Capital came in at $271.2 million for Q1 2026 at Beta Bionics, down from $287.6 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $313.8 million in Q1 2025 to a low of -$245.4 million in Q4 2024.
• A 4-year average of $35.6 million and a median of $34.1 million in 2023 frame the typical range for Invested Capital.
• Across the five-year window, Invested Capital decreased 20.8% in 2024 and surged 246.39% in 2025, its largest moves.
• Beta Bionics' Invested Capital stood at -$203.1 million in 2023, then dropped by 20.8% to -$245.4 million in 2024, then soared by 217.22% to $287.6 million in 2025, then declined by 5.69% to $271.2 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $271.2 million, $287.6 million, and $294.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison